卫光生物
(002880)
| 流通市值：62.12亿 | | | 总市值：62.12亿 |
| 流通股本：2.27亿 | | | 总股本：2.27亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 79,599,872.52 | 135,985,076.18 | 305,093,236.08 | 274,763,226.74 |
| 应收票据及应收账款 | 262,601,652.9 | 261,348,414.97 | 246,310,087.14 | 284,261,691.18 |
| 其中：应收票据 | 87,137,281.56 | 91,304,952.99 | 120,605,625.3 | 151,400,054.78 |
| 应收账款 | 175,464,371.34 | 170,043,461.98 | 125,704,461.84 | 132,861,636.4 |
| 预付款项 | 6,394,700.16 | 4,122,965.71 | 5,990,082.08 | 2,133,760.33 |
| 其他应收款合计 | 24,112,590.38 | 23,769,837.77 | 18,248,867.61 | 17,075,115.44 |
| 存货 | 966,635,488.07 | 898,157,234.32 | 858,849,927.81 | 793,462,099.62 |
| 一年内到期的非流动资产 | - | - | 99,053,569.41 | 153,315,430.54 |
| 其他流动资产 | 6,012,759.57 | 4,427,309.94 | 1,100,324.87 | 2,579,062.65 |
| 流动资产合计 | 1,345,357,063.6 | 1,327,810,838.89 | 1,534,646,095 | 1,527,590,386.5 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 77,669,283.18 | 77,669,283.18 | 77,669,283.18 | 77,669,283.18 |
| 投资性房地产 | 869,342,520.53 | 776,604,429.63 | 788,734,282.92 | 800,940,962.12 |
| 固定资产 | 592,565,968.56 | 677,025,810.27 | 619,207,230.66 | 633,893,005.81 |
| 在建工程 | 13,207,428.73 | 10,082,725.05 | 53,528,490.27 | 42,231,714.38 |
| 使用权资产 | 14,087,151.36 | 14,329,423.38 | 14,571,695.4 | 14,960,451.06 |
| 无形资产 | 152,383,603.43 | 130,956,569.64 | 133,144,344.8 | 134,911,011.12 |
| 开发支出 | 35,763,539.91 | 28,701,834.6 | 26,458,404.46 | 26,458,404.46 |
| 商誉 | 19,230,057.19 | 19,230,057.19 | 19,230,057.19 | 19,230,057.19 |
| 长期待摊费用 | 9,499,354.24 | 9,553,214.62 | 3,556,857.39 | 1,877,233.49 |
| 递延所得税资产 | 10,465,681.38 | 10,079,255.62 | 9,620,262.38 | 9,969,591.92 |
| 其他非流动资产 | 254,524,692.07 | 260,413,085.29 | 10,317,000.41 | 7,712,131.96 |
| 非流动资产合计 | 2,048,739,280.58 | 2,014,645,688.47 | 1,756,037,909.06 | 1,769,853,846.69 |
| 资产总计 | 3,394,096,344.18 | 3,342,456,527.36 | 3,290,684,004.06 | 3,297,444,233.19 |
| 流动负债: | | | | |
| 短期借款 | 126,381,320.36 | 100,000,000 | 100,000,000 | 100,066,666.67 |
| 应付票据及应付账款 | 134,678,141.59 | 129,508,279.22 | 127,814,494.07 | 137,141,912.73 |
| 其中：应付票据 | 10,927,064.02 | - | - | - |
| 应付账款 | 123,751,077.57 | 129,508,279.22 | 127,814,494.07 | 137,141,912.73 |
| 预收款项 | 104,852.5 | 92,705 | 25,420 | 68,774.5 |
| 合同负债 | 7,633,158.46 | 769,572.82 | 810,213.59 | 759,938.15 |
| 应付职工薪酬 | 79,521,146.25 | 70,430,322.26 | 93,105,339.54 | 107,582,698.32 |
| 应交税费 | 20,359,250.99 | 21,960,799.55 | 12,970,721.33 | 17,448,651.59 |
| 其他应付款合计 | 43,288,606.59 | 84,135,101.37 | 33,404,593.64 | 43,278,115.62 |
| 应付股利 | - | 45,360,000 | - | - |
| 一年内到期的非流动负债 | 48,510,038.64 | 48,400,498.93 | 44,565,499.61 | 16,383,848.76 |
| 其他流动负债 | 330,881.54 | 23,087.18 | 24,306.41 | 22,798.14 |
| 流动负债合计 | 460,807,396.92 | 455,320,366.33 | 412,720,588.19 | 422,753,404.48 |
| 非流动负债: | | | | |
| 长期借款 | 495,642,292.42 | 506,502,651.42 | 514,526,477.9 | 554,097,313.52 |
| 租赁负债 | 15,932,675.17 | 15,760,074.91 | 15,585,757.61 | 15,318,253.62 |
| 递延收益 | 47,878,196.87 | 41,070,520.14 | 42,182,002.29 | 43,268,148.09 |
| 递延所得税负债 | 11,090,156.41 | 11,300,107.62 | 11,657,937.36 | 11,719,405.39 |
| 其他非流动负债 | 6,052,844.11 | 6,052,844.11 | 6,051,242.92 | 6,051,242.92 |
| 非流动负债合计 | 576,596,164.98 | 580,686,198.2 | 590,003,418.08 | 630,454,363.54 |
| 负债合计 | 1,037,403,561.9 | 1,036,006,564.53 | 1,002,724,006.27 | 1,053,207,768.02 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 226,800,000 | 226,800,000 | 226,800,000 | 226,800,000 |
| 资本公积 | 563,493,192.55 | 563,493,192.55 | 563,493,192.55 | 563,493,192.55 |
| 盈余公积 | 194,612,071.44 | 194,612,071.44 | 194,612,071.44 | 194,612,071.44 |
| 未分配利润 | 1,339,020,604.4 | 1,288,806,412.62 | 1,270,288,237 | 1,226,520,067.15 |
| 归属于母公司股东权益合计 | 2,323,925,868.39 | 2,273,711,676.61 | 2,255,193,500.99 | 2,211,425,331.14 |
| 少数股东权益 | 32,766,913.89 | 32,738,286.22 | 32,766,496.8 | 32,811,134.03 |
| 股东权益合计 | 2,356,692,782.28 | 2,306,449,962.83 | 2,287,959,997.79 | 2,244,236,465.17 |
| 负债和股东权益合计 | 3,394,096,344.18 | 3,342,456,527.36 | 3,290,684,004.06 | 3,297,444,233.19 |
| 公告日期 | 2025-10-31 | 2025-08-30 | 2025-04-23 | 2025-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |